Abstract:Early diagnosis is critical for improving the outcome of patients with renal cell carcinoma (RCC). In this study, we applied a proteomic approach to identify serum biomarkers associated with different stages of renal tumor development.The protein expression profiles in patient serum samples were analyzed using surface enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI-TOF-MS). The subjects included 65 patients with renal cell carcinomas, 34 with benign renal tumors, and 69 normal controls. A diagnostic decision tree was developed and validated based on the differentially expressed proteins between the serum of patients with small (<or=3 cm) RCC tumors and normal controls.The numbers of proteins differentially expressed in the serum samples were 29 between the patients with RCC and normal controls, 18 between patients with RCC and benign renal tumors, and 35 between patients with small RCC tumors and normal controls, respectively. The diagnostic decision tree generated from the differentially expressed proteins between patients with small RCC tumors and normal controls proved efficient in the early diagnosis of renal cell carcinoma, with a sensitivity of 81.8% and specificity of 100%. The eukaryotic initiation factor 2B delta subunit (eIF2B-delta) was identified as the most highly up-regulated protein in the serum of patients with RCC.SELDI-TOF-MS is a simple, sensitive and highly reproducible technique that can be used to identify serum biomarkers. The serum biomarkers identified by this study may facilitate early diagnosis of RCC and offer new targets for mechanistic understanding and clinical therapy of this disease.

Evaluation of the Capability of SELDI-TOF-MS Detecting Protein from Urine After Renal Transplantation

Analysis of Urinary Proteomic Patterns for Diabetic Nephropathy by ProteinChip.

Analysis of Urinary Protein Patterns for Diabetes by Protein Chip

Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.

Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early Iga Nephropathy

Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis

Screening urine markers of renal cell carcinoma using SELDI-TOF-MS]

Diagnosis of Renal Allograft Subclinical Rejection by Urine Protein Fingerprint Analysis.

Diagnosis of C4d+ Renal Allograft Acute Humoral Rejection by Urine Protein Fingerprint Analysis.

Correlation of surface-enhanced Raman spectroscopic fingerprints of kidney transplant recipient urine with kidney function parameters

Identification of the Pathologic Presentation of Clinical Early IgA Nephropathy by MALDI-TOF-MS with Magnetic Beads

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

[Construction of Protein Fingerprint Signature in Serum and Its Significance for Early Diagnosis with Chronic Allograft Nephropathy].

Prediction of Acute Cellular Renal Allograft Rejection by Urinary Metabolomics Using MALDI-FTMS

Application of immune cell functional assay in monitoring immune status in renal transplant recipients

Establishing a diagnostic model for clinical almost tolerance of kidney allograft based upon plasma proteomics

SELDI-TOF-MS ProteinChip Technology for Screening of Urine Markers of Bladder Carcinoma

Screening of biomarkers in urine of rats with minimally-changed nephrotic syndrome by surface enhanced laser desorption/ionization time of flight-mass spectrometry

Urinary Protein Profile of Impaired Fasting Glucose Subjects with Normal AIbuminuria

Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.

Proteome analysis of diabetic nephropathy urinary